Presentation TCT 2023 TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry) Presenter: Wojciech Wanha October 24, 2023
News Daily News Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry Todd Neale October 16, 2023
News Conference News LINC 2023 PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD L.A. McKeown June 21, 2023
News Conference News LINC 2023 Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil L.A. McKeown June 09, 2023
News Conference News LINC 2023 FDA Approves DETOUR for Percutaneous Bypass in Long, Complex SFA L.A. McKeown June 08, 2023
News Conference News ISET 2023 BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions Caitlin E. Cox January 20, 2023
News Conference News Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices L.A. McKeown November 18, 2022
News Conference News VIVA 2022 TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years L.A. McKeown November 03, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2022 Caitlin E. Cox July 04, 2022
News Conference News SCAI 2022 SAFE-PAD Provides More Long-term Safety Data for Paclitaxel L.A. McKeown May 22, 2022
News Daily News Routine IVUS in Peripheral Interventions Supported by Small RCT L.A. McKeown March 09, 2022
News Industry News IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly January 22, 2022
News Conference News VIVA 2021 EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions L.A. McKeown October 12, 2021
News Conference News VIVA 2021 Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI L.A. McKeown October 08, 2021
News Conference News VIVA 2021 Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms L.A. McKeown October 07, 2021
News Conference News ACC 2021 SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal L.A. McKeown May 16, 2021